XML 97 R82.htm IDEA: XBRL DOCUMENT v3.22.2.2
Income Tax (Details) - Schedule of deferred tax assets (liability) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Deferred tax assets:    
Net operating loss carryforward $ 59,916,000 $ 54,018,000
Research and development credit carryforwards 13,675,000 12,003,000
Scientific research and experimental development deductions 23,071,000 20,137,000
Depreciation and amortization 5,634,000 5,256,000
Convertible notes (4,000) 1,156,000
Deferred revenue 165,000 401,000
Other accruals and reserves 730,000 440,000
Total deferred tax assets 103,187,000 93,411,000
Valuation Allowance (97,143,000) (89,139,000)
Total deferred tax assets, net 6,044,000 4,272,000
Deferred tax liabilities:    
Marketable securities (315,000) 0
Loans payable (5,729,000) (4,272,000)
Total deferred tax liabilities (6,044,000) (4,272,000)
Net deferred tax assets 0 0
DPCM Capital, Inc. [Member]    
Deferred tax assets:    
Net operating loss carryforward 25,292 72,074
Startup/Organizational Expenses 816,763 0
Unrealized gain on marketable securities (889) (12,280)
Total deferred tax assets 841,166 59,794
Valuation Allowance (841,166) (59,794)
Total deferred tax assets, net